TRVI 8-K 2026-11-09

Trevi Therapeutics, Inc. (TRVI) 8-K dated 2026-11-09 — accession 0001193125-26-453670.

Trevi Therapeutics, Inc. (TRVI) is a biotechnology company listed on NASDAQ.

Trevi Therapeutics, Inc. filed a 8-K on 2026-11-09. Accession 0001193125-26-453670.

This 8-K covers: Results of operations (Item 2.02), Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.

Income-statement cache for TRVI is thin on this filing URL. We will not invent exhibit numbers.

Not investment advice. The TRVI SEC hub lists recent forms. The stock page is the research view.